Clinical Trials Browser

Phase 2 × Neurofibroma, Plexiform × cabozantinib × Clear all

NCT02101736 2023-05-24

NF105-CABO

Phase 2 Completed

45 enrolled 10 charts

Neurofibromatoses, Neurofibroma, Plexiform